Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.83
+0.31 (3.26%)
At close: Apr 9, 2026, 4:00 PM EDT
9.85
+0.02 (0.20%)
After-hours: Apr 9, 2026, 5:01 PM EDT

Vir Biotechnology Revenue

In the year 2025, Vir Biotechnology had annual revenue of $68.56M, down -7.61%. Vir Biotechnology had revenue of $64.07M in the quarter ending December 31, 2025, with 417.78% growth.

Revenue (ttm)
$68.56M
Revenue Growth
-7.61%
P/S Ratio
22.77
Revenue / Employee
$186,801
Employees
367
Market Cap
1.57B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202568.56M-5.65M-7.61%
Dec 31, 202474.21M-11.98M-13.90%
Dec 31, 202386.18M-1.53B-94.67%
Dec 31, 20221.62B520.38M47.51%
Dec 31, 20211.10B1.02B1,334.40%
Dec 31, 202076.37M68.28M843.86%
Dec 31, 20198.09M-2.58M-24.16%
Dec 31, 201810.67M7.96M293.94%
Dec 31, 20172.71M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ardelyx407.32M
Viridian Therapeutics70.85M
Nuvation Bio62.90M
Immatics56.67M
Precigen9.68M
AtaiBeckley4.09M
Maze Therapeutics2.50M
Revenue Rankings